Anna Geiger
banner
annageiger.bsky.social
Anna Geiger
@annageiger.bsky.social
Operations Coordinator @ The Institute for Clinical & Economic Review | Cognitive Psychology Research Assistant @ Northeastern University
Reposted by Anna Geiger
Vertex prices suzetrigine (Journavx) at $31/day. ICER’s report finds it cost-saving.

Better than placebo in trials but that doesn’t mean much.

Similar effect to 5 mg oxy/325 mg tylenol for tummy tuck but slower for bunionectomy. Sample size very small. www.technologynetworks.com/tn/news/us-a...
US Approves Non-Opioid Painkiller: What Is It, and How Does It Work?
The US Food and Drug Administration (FDA) announced its approval of a non-opioid treatment for moderate–severe acute chronic pain. The drug, Journavx™ (suzetrigine), represents the first new class of ...
www.technologynetworks.com
January 31, 2025 at 2:05 PM